RTX stock at a fresh 52-week high: what to watch before Jan. 27 earnings

RTX stock at a fresh 52-week high: what to watch before Jan. 27 earnings

New York, Jan 19, 2026, 14:57 ET — The market has closed.

RTX Corp (NYSE: RTX) pushed to a new 52-week closing high on Friday, rising 1.05% to $201.92 and marking its seventh straight session of gains. The aerospace and defense giant also notched a fresh 52-week intraday peak, surpassing the $200.31 high set just a day earlier. 1

U.S. equity markets were closed Monday for Martin Luther King Jr. Day, leaving investors to digest Friday’s data ahead of Tuesday’s session. 2

Risk appetite has cooled since late last week. Global markets stumbled after President Donald Trump revived tariff threats linked to the Greenland dispute. Reuters reported that U.S. stock futures also took a hit ahead of the holiday break. “I’m sure that there are a lot of people that are fairly aghast,” Francesca Fornasari, head of currency solutions at Insight Investment, told Reuters. 3

RTX holders have a clear date to mark down. The company plans to release its fourth-quarter and full-year 2025 earnings on Tuesday, Jan. 27, before markets open. A conference call will follow at 8:30 a.m. ET. 4

Attention now shifts to guidance—the company’s forecast—over the quarterly results themselves. Following a week of gains, traders are ready to gauge how much of the positive momentum is already baked into the stock.

Investors are keenly awaiting updates on delivery schedules within commercial aerospace and shifts in demand for defense projects. Beyond the figures, the tone of the commentary will carry weight, especially regarding cash-flow forecasts.

Defense stocks have tended to weather market dips more resiliently in recent sessions. Northrop Grumman gained 1.88% on Friday, hitting a fresh 52-week peak, according to market data. 5

The list of potential disruptions is far from short. If Tuesday’s open sees a wider de-risking—whether sparked by tariffs, interest rates, or a mix of both—those so-called “steady” industrials could feel the pressure too.

RTX faces a straightforward near-term risk: expectations. With seven gains in a row, any cautious remarks about 2026 margins or deliveries might spark profit-taking, even if the results roughly match forecasts.

Tuesday’s reopening is next, followed by RTX’s January 27 report and outlook call — the first major event on the calendar that could shift the stock’s momentum.

Stock Market Today

Singtel share price cools after STT GDC deal surge, with earnings date now in focus

Singtel share price cools after STT GDC deal surge, with earnings date now in focus

7 February 2026
Singapore, Feb 7, 2026, 14:55 (SGT) — Market closed. Singapore Telecommunications Ltd shares ended Friday down 1.3% at S$4.72, extending a two-day pullback after the stock hit a fresh high earlier in the week on its data centre acquisition plan with KKR. With Singapore markets shut for the weekend, traders head into Monday watching whether the dip draws buyers or turns into something more stubborn. 1 The move matters now because Singtel has become a popular, liquid proxy for Singapore investors looking for steady dividends — and for a cleaner way to play the region’s build-out of data centres tied
SGX share price dips at week’s end after record profit; what investors watch next

SGX share price dips at week’s end after record profit; what investors watch next

7 February 2026
Singapore Exchange shares closed 0.4% lower at S$17.57 on Friday, despite reporting record half-year results and a higher dividend earlier in the week. Broker targets diverged after the update, with Maybank and DBS raising targets while Citi stayed bearish. Investors are watching for signs of momentum from derivatives and equity-market reforms as the next session opens Monday.
Wells Fargo stock in focus as Wall Street reopens and Trump’s credit-card rate cap deadline hits
Previous Story

Wells Fargo stock in focus as Wall Street reopens and Trump’s credit-card rate cap deadline hits

Novo Nordisk stock drops in Copenhagen as Wegovy pill demand gets its first real test
Next Story

Novo Nordisk stock drops in Copenhagen as Wegovy pill demand gets its first real test

Go toTop